<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>1H magnetic resonance spectroscopy (MRS) allows accurate and non-invasive in vivo metabolic study, and is a useful tool for the diagnosis of different forms of <z:hpo ids='HP_0000726'>dementias</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0100543'>Cognitive impairment</z:hpo> pathologies have been almost exclusively studied with MRS by comparison with healthy without a global comparison amongst <z:hpo ids='HP_0002511'>Alzheimer disease</z:hpo> (AD), vascular <z:hpo ids='HP_0000726'>dementia</z:hpo>, mild <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> (MCI) and major <z:hpo ids='HP_0000716'>depression</z:hpo> patients with <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Whereas decrease of N-acetylaspartate (<z:chebi fb="8" ids="32918">NAA</z:chebi>) and increase <z:chebi fb="0" ids="17268">myo-Inositol</z:chebi> (mI) at different brain locations by 1H MRS are common features of AD, <z:chebi fb="3" ids="15354">Choline</z:chebi> (Cho) alterations have been inconclusive </plain></SENT>
<SENT sid="3" pm="."><plain>In our study, 64 patients with <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> were evaluated by 1H MRS using two echo times (31 and 136 ms) </plain></SENT>
<SENT sid="4" pm="."><plain>There were statistical differences between <z:hpo ids='HP_0000726'>dementia</z:hpo> (AD and vascular <z:hpo ids='HP_0000726'>dementia</z:hpo>) and non-<z:hpo ids='HP_0000726'>dementia</z:hpo> (MCI and <z:hpo ids='HP_0000716'>depression</z:hpo>) spectra at posterior cingulate gyrus </plain></SENT>
<SENT sid="5" pm="."><plain>Cho/Cr, mI/Cr and <z:chebi fb="8" ids="32918">NAA</z:chebi>/Cr have been valuables for the differentiation amongst the different <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> entities </plain></SENT>
<SENT sid="6" pm="."><plain><z:chebi fb="8" ids="32918">NAA</z:chebi>/mI provides the best area under the ROC curve with the highest sensitivity (82.5%) and specificity (72.7%) in diagnosing AD </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="8" ids="32918">NAA</z:chebi>/mI and mI/Cr ratios differed amongst the four <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> degenerative pathologies </plain></SENT>
<SENT sid="8" pm="."><plain>Metabolic MRS differences found amongst patients with <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> entities can be useful to differentiate between AD, vascular <z:hpo ids='HP_0000726'>dementia</z:hpo>, MCI and <z:hpo ids='HP_0000716'>depression</z:hpo> </plain></SENT>
</text></document>